Cargando…
WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
Philadelphia (Ph*)/BCR-ABL1-positive chronic myeloid leukemia (CML) is considered as a chronic life-long disease, which could be manageable with tyrosine kinase inhibitor (TKI) drugs. The aim of TKI drug treatment is to provide age- and sex-matched duration of life in a given patient with CML. Perso...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Galenos Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057757/ https://www.ncbi.nlm.nih.gov/pubmed/31612694 http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0241 |